Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of LifeMD Inc (NASDAQ: LFMD) was $3.5 for the day, down -6.17% from the previous closing price of $3.73. In other words, the price has decreased by -$6.17 from its previous closing price. On the day, 1.24 million shares were traded. LFMD stock price reached its highest trading level at $3.75 during the session, while it also had its lowest trading level at $3.475.
Ratios:
Our analysis of LFMD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.06. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 0.73. In the meantime, Its Debt-to-Equity ratio is 4.98 whereas as Long-Term Debt/Eq ratio is at 4.47.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on June 18, 2025, Reiterated its Buy rating but revised its target price to $18 from $15 previously.
On December 10, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.Mizuho initiated its Neutral rating on December 04, 2024, with a $7 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 24 ’25 when FRIEDEMAN JESSICA bought 20,000 shares for $4.04 per share.
Alvarez Nicholas P sold 75,000 shares of LFMD for $443,760 on Sep 10 ’25. The Chief Acquisition Officer now owns 605,000 shares after completing the transaction at $5.92 per share. On Sep 10 ’25, another insider, Alvarez Nicholas P, who serves as the Officer of the company, bought 75,000 shares for $6.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 168475600 and an Enterprise Value of 153268944. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67 while its Price-to-Book (P/B) ratio in mrq is 124.07. Its current Enterprise Value per Revenue stands at 0.613 whereas that against EBITDA is -112.506.
Stock Price History:
The Beta on a monthly basis for LFMD is 1.45, which has changed by -0.40677965 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $15.84, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is -35.58%, while the 200-Day Moving Average is calculated to be -53.70%.
Shares Statistics:
LFMD traded an average of 1.22M shares per day over the past three months and 1173440 shares per day over the past ten days. A total of 46.58M shares are outstanding, with a floating share count of 39.28M. Insiders hold about 18.40% of the company’s shares, while institutions hold 42.89% stake in the company. Shares short for LFMD as of 1763078400 were 4389291 with a Short Ratio of 3.59, compared to 1760486400 on 4173616. Therefore, it implies a Short% of Shares Outstanding of 4389291 and a Short% of Float of 10.92.
Earnings Estimates
. The current rating of LifeMD Inc (LFMD) is the result of assessments by 2.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $0.03, with high estimates of $0.12 and low estimates of -$0.07.
Analysts are recommending an EPS of between $0.42 and -$0.23 for the fiscal current year, implying an average EPS of $0.09. EPS for the following year is $0.14, with 2.0 analysts recommending between $0.55 and -$0.26.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 8 analysts. It ranges from a high estimate of $58M to a low estimate of $45M. As of. The current estimate, LifeMD Inc’s year-ago sales were $64.25MFor the next quarter, 8 analysts are estimating revenue of $50.07M. There is a high estimate of $58.75M for the next quarter, whereas the lowest estimate is $47.1M.
A total of 8 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $246.1M, while the lowest revenue estimate was $233.09M, resulting in an average revenue estimate of $236.72M. In the same quarter a year ago, actual revenue was $212.45MBased on 8 analysts’ estimates, the company’s revenue will be $224.04M in the next fiscal year. The high estimate is $249.2M and the low estimate is $197M.
